pThailand’s residents and tourists will soon be able to breathe easily. It has just been announced that a vaccine designed to protect against the type-A (H1N1) virus will soon be fit for human trials. Next month, the Government Pharmaceuti-cal Organisation will start carrying out human trials the live-attenuated vaccine produced by laboratories in the Netherlands and Russia./p
pIt shouldn’t be long before the vaccine is available in Thailand and will be available for people concerned about contracting the type-A (H1N1) virus. If things go according to plan, the vaccine will be available at major hospitals in all of Thailand’s tourism hotspots, including Bangkok and a href=”http://1stoppattaya.com”Pattaya/a. /p
pIn a press statement reported by a href=”http://nationmultimedia.com”The Nation/a GPO’s board chairperson Dr Wichai Chotewiwat confirmed that the virus-seed vaccine has already proven to be safe on animals: “The e-mails say that the virus-seed vaccine proved to be safe on animals and that there were no toxins or mutation,” he said, adding that: “More samples need to be tested before we can confirm the virus is resistant.”/p
pDr Wichai revealed that this week the GPO would be receiving the first few doses of FluMist, which is a nasal spray live-attenuated vaccine. /p